Dicot Pharma AB (publ)
Climate Impact & Sustainability Data (2022-01-01 to 2023-12-31)
Reporting Period: 2022-01-01 to 2023-12-31
Environmental Metrics
Total Carbon Emissions:Not disclosed
Scope 1 Emissions:Not disclosed
Scope 2 Emissions:Not disclosed
Scope 3 Emissions:Not disclosed
Renewable Energy Share:Not disclosed
Total Energy Consumption:Not disclosed
Water Consumption:Not disclosed
Waste Generated:Not disclosed
Carbon Intensity:Not disclosed
ESG Focus Areas
- Not disclosed
Environmental Achievements
- Not disclosed
Social Achievements
- Not disclosed
Governance Achievements
- Not disclosed
Climate Goals & Targets
Long-term Goals:
- Develop LIB-01 into a drug for the global market.
Medium-term Goals:
- Enter into partnerships with larger pharmaceutical companies to finance and further develop LIB-01.
Short-term Goals:
- Complete clinical phase 2a study and prepare for phase 2b study.
Environmental Challenges
- Dependence on suppliers, manufacturers, and collaboration partners for development and future commercialization of LIB-01. Risk of delays in finding suitable partners, additional studies required before agreements, supplier inability to deliver raw materials, or partners terminating collaborations.
- Potential for adverse events in clinical trials, leading to delays or cessation of development. Limited insurance coverage for potential claims.
- Future capital needs for continued clinical studies. Uncertainty regarding the size and timing of future capital requirements.
Mitigation Strategies
- Collaboration with world-leading partners for LIB-01 development (Thermo Fisher Scientific).
- Ongoing interactions with relevant authorities to minimize the risk of requiring supplements before clinical study approval.
- Current offering of units aims to secure funding for clinical phase 2a and preparations for phase 2b.
Supply Chain Management
Supplier Audits: Not disclosed
Responsible Procurement
- Following the Nagoya Protocol on Access and Benefit Sharing for sustainable harvesting of raw materials.
Climate-Related Risks & Opportunities
Physical Risks
- Not disclosed
Transition Risks
- Not disclosed
Opportunities
- Not disclosed
Reporting Standards
Frameworks Used: Null
Certifications: Null
Third-party Assurance: Not disclosed
UN Sustainable Development Goals
- Not disclosed
Not disclosed
Sustainable Products & Innovation
- Not disclosed
Awards & Recognition
- Not disclosed